Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 4 4Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Completed 9Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 74Other solid neoplasm 50Lymphoid 36Breast 33Thoracic 31Genitourinary 31Other hematologic neoplasm 24Head & Neck 18CNS 18Plasma cell 15Gynecologic 15Dermatologic 8Sarcoma 6Tumor-Agnostic 5Other neoplasm 2Myeloid 2Other 1Endocrine 1Classical hematology 1

Conditions

Sexual Dysfunctions, Psychological 1Breast Neoplasms 1

Interventions

exemestane 1Leuprolide 1Letrozole 1Goserelin 1Gonadotropin-Releasing Hormone 1Bupropion 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Other × Clear all
NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

University of Illinois at Chicago

Phase 1/2 Not yet recruiting
100 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡